The most comprehensive study of its kind showed that psychotic disorders, infections and dementia were among conditions found to be less likely to occur when using GLP-1RAs, which are found in the medications Saxenda, Wegovy and Mounjaro.
The researchers compared health outcomes for people with diabetes who received usual care with those also given drugs such as liraglutide, semaglutide and tirzepatide. While the team revealed the risk of many conditions was lower for the latter group, the risk of other conditions, including arthritic disorders, was increased.
And the scientists say that the benefits are not just restricted to people with diabetes, suggesting they could also be found in other people using the jabs, such as those who take them to fight obesity.
People who passed health based selection to trial new medications were found to be healthy.
I admittedly didn’t read the article (no time as I speak), but surely they included a control group?
In truth I didn’t it read either, I was just making a glib comment. I do know that unlike the rest of science medical science dealing with people often selects patients via hospitals and this introduces bias, intentional or hopefully accidental into the selection process. A great deal of patient history is known during selection, unhealthy patients not chosen for trial drugs but allowed onto the control. Maybe I am just getting cynical.
They got that dawg in 'em